Current perspectives on recurrent pituitary adenoma: The role and timing of surgery vs adjuvant treatment

Caroline Hayhurst(University Hospital of Wales), John Davies(National Institutes of Health), Andrew Lansdown(Royal Prince Alfred Hospital), Nachi Palaniappan(Velindre Cancer Centre), Peter Taylor(University Hospital of Wales), Aled Rees(University of Wales)
Clinical Endocrinology
November 12, 2019
10.1111/cen.14127
Cited by 35

Related Papers

Global epidemiology of hyperthyroidism and hypothyroidism
|Nature Reviews Endocrinology|2018|1.5k
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
|The Lancet|2023|838
Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth
|JAMA|2019|395
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy
|Nature Reviews Endocrinology|2019|315
Falling Threshold for Treatment of Borderline Elevated Thyrotropin Levels—Balancing Benefits and Risks
|JAMA Internal Medicine|2013|299